DeRoyal Recalls Surgical Procedure Packs for Mislabeled Lidocaine

Serious injuries or death may result from the use of these devices. The FDA has identified this as a Class I recall, the most serious type.

If your email program has trouble displaying this email, view as a webpage. DeRoyal Industries Recalls Surgical Procedure Packs for Mislabeled Lidocaine DeRoyal is recalling the surgical procedure packs because the packs contain 1% lidocaine that has been mislabeled as 0.5% bupivacaine. This recall is related to Hospira's recall for the same mislabeling issue. The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Read More Questions? If you have questions about this recall, contact the Division of Industry and Consumer Education.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA